Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0249
- Available Online
- View Pamphlet
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Anticoagulants
- Subjects (LCSH)
- Anticoagulants (Medicine)
- Specialty
- Medications
- Abstract
- This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0249
Handbook of oral anticoagulation
https://libcat.nshealth.ca/en/permalink/provcat33540
editors, Gregory YH Lip, Eduard Shantsila ; contributors, Deirdre A. Lane, Chee W. Khoo, Kok Hoon Tay, Suresh Krishnamoorthy, Stavros Apostolakis.
(Second edition)
--London:
Springer Healthcare
, c2013.
- Available Online
- View e-Book
- Location
- Online
This book covers a wide range of disorders such as atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism and stroke. Handbook of Oral Anticoagulation aims to provide an accessible overview of the exciting new developments in this field. Incorporating numerous quick-reference tables and figures and fully referenced throughout to key papers and the latest reviews, it will be a useful resource for all healthcare professionals involved in thromboprophylaxis.
- Available Online
- View e-Book
- Other Authors
- Lip, Gregory Y. H
- Shantsila, Eduard
- Responsibility
- editors, Gregory YH Lip, Eduard Shantsila ; contributors, Deirdre A. Lane, Chee W. Khoo, Kok Hoon Tay, Suresh Krishnamoorthy, Stavros Apostolakis
- Edition
- Second edition
- Place of Publication
- London
- Publisher
- Springer Healthcare
- Date of Publication
- c2013
- Physical Description
- 1 online resource (ix, 88 pages)
- ISBN
- 9781908517968 (electronic bk.)
- 9781908517586
- Subjects (MeSH)
- Anticoagulants - administration & dosage
- Anticoagulants - adverse effects
- Anticoagulants - therapeutic use
- Subjects (LCSH)
- Anticoagulants - Handbooks
- Anticoagulants (Medicine)
- Cardiology
- Hematology
- General Practice / Family Medicine
- Primary Care Medicine
- Pharmacotherapy
- Abstract
- This book covers a wide range of disorders such as atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism and stroke. Handbook of Oral Anticoagulation aims to provide an accessible overview of the exciting new developments in this field. Incorporating numerous quick-reference tables and figures and fully referenced throughout to key papers and the latest reviews, it will be a useful resource for all healthcare professionals involved in thromboprophylaxis.
- Contents
- The Coagulation Pathway and Approaches to Anticoagulation -- Common Clinical Indications for Anticoagulation -- Vitamin K Antagonists and Their Limitations -- Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues -- New Oral Anticoagulants -- Future Directions.
- Format
- e-Book
- Location
- Online
Nova Scotia Health Authority. QEII. Cardiology.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1496
- Available Online
- View Pamphlet
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Cardiology
- Alternate Title
- Brilinta
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Platelet Aggregation Inhibitors - therapeutic use
- Adenosine - therapeutic use
- Cardiovascular Diseases - prevention & control
- Myocardial Infarction - prevention & control
- Pulmonary Embolism - prevention & control
- Subjects (LCSH)
- Adenosine
- Anticoagulants (Medicine)
- Cardiovascular system--Diseases--Prevention
- Myocardial infarction--Prevention
- Abstract
- Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
- Responsibility
- Prepared by: Cardiology
- Pamphlet Number
- 1496
Warfarine sodique
https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 2063
- Available Online
- View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Alternate Title
- Coumadin
- Warfarin sodium
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Warfarin
- Anticoagulants
- Subjects (LCSH)
- Warfarin
- Anticoagulants (Medicine)
- Abstract
- Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
- This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
- Responsibility
- Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
- Pamphlet Number
- 2063
Warfarin sodium
https://libcat.nshealth.ca/en/permalink/chpams36501
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Hematology Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 0373
- Available Online
- View Pamphlet
Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the An…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Services
- Nova Scotia Health Authority. QEII. Hematology Services
- Alternate Title
- Coumadin
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Warfarin
- Anticoagulants
- Subjects (LCSH)
- Warfarin
- Anticoagulants (Medicine)
- Specialty
- Medications
- Abstract
- Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the Anticoagulation Clinic and the Thrombosis Anticoagulation Program is provided. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
- Notes
- Previous title: Warfarin sodium, an oral anticoagulant
- Responsibility
- Prepared by: Pharmacy Services and Hematology Services, QEII
- Pamphlet Number
- 0373
